Mirae Asset Global Investments Co., Ltd.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1569395
SEOUL, M5
Position in INDV
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$442,051
New position
Shares Held
14,503
first reported quarter
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Mirae Asset Global Investments Co., Ltd. holds $22,631,351 across 30 Drug Manufacturers - Specialty & Generic names. INDV ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
94,998 | $11,229,712 | |
| 2 | VTRS |
Viatris Inc
|
283,050 | $3,824,005 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
4,828 | $2,862,907 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
10,408 | $1,371,149 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
14,385 | $692,637 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
21,502 | $514,542 | |
| 7 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
14,503 | $442,051 | |
| 8 | ALKS |
Alkermes plc.
|
8,692 | $307,349 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $442,051 | 14,503 | Shares | Sole | 2026-05-04 | |
| No filing history on record for this holder in this stock. | ||||||